Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” The Multidomain Alzheimer Preventive Trial (MAPT): A new approach to the prevention of Alzheimer's disease
Authors:
- Sophie Gillette‐GuyonnetSGSophie Gillette‐Guyonnet
- MAPT Study GroupMGMAPT Study Group
- 1 March 2009
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 5 (2) , 114-121
Abstract
Background: Because no effective curative approaches are available, preventive approaches in the field of Alzheimer's disease (AD) are needed. We present the design of the ongoing Multidomain Alzheimer Preventive Trial (MAPT) Study. Several previous studies suggested that many factors may be involved in the occurrence of AD at late ages. Because of the probable multifactorial nature of AD, it seems logical to initiate multidomain interventions to examine their potential synergistic effects. The MAPT Study aims to evaluate the efficacy of a multidomain intervention (nutritional, physical, and cognitive training) and omega 3 treatment in the prevention of cognitive decline in frail elderly persons aged 70 years or over. The study also collects imaging and biological data that could be used in future AD prevention and treatment trials.Methods: The MAPT Study is a 3‐year, randomized, controlled trial conducted by university hospital practitioners specializing in memory disorders in four French cities (Bordeaux, Limoges, Montpellier, and Toulouse). The study plans to enroll 1200 frail elderly subjects on the basis of at least one of the following criteria: subjective memory complaint spontaneously expressed to a general practitioner, limitation in one instrumental activity of daily living (IADL), and slow walking speed. To demonstrate the protective effect of interventions, subjects are randomized into one of the following four groups: omega 3 alone, multidomain intervention alone, omega 3 plus multidomain intervention, or placebo (n = 300 each). The principal outcome measure is a change in cognitive function at 3 years, as determined by the Grober and Buschke Test.Conclusions: The MAPT Study is the first preventive trial involving multidomain interventions. Final results should be available in 2013.Keywords
Funding Information
- Centre Hospitalier Universitaire de Toulouse
This publication has 38 references indexed in Scilit:
- Relationship Between Frailty and Cognitive Decline in Older Mexican AmericansJournal of the American Geriatrics Society, 2008
- Physical frailty in older persons is associated with Alzheimer disease pathologyNeurology, 2008
- Endpoints for trials in Alzheimer's disease: a European task force consensusThe Lancet Neurology, 2008
- Standardizing Assessment of Elderly People in Acute Care: The interRAI Acute Care InstrumentJournal of the American Geriatrics Society, 2008
- The I.A.N.A. task force on frailty assessment of older people in clinical practiceThe Journal of nutrition, health and aging, 2008
- Long-term Effects of Cognitive Training on Everyday Functional Outcomes in Older AdultsJAMA, 2006
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982
- Development and validation of a geriatric depression screening scale: A preliminary reportJournal of Psychiatric Research, 1982
- Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily LivingThe Gerontologist, 1969
- Studies of Illness in the AgedJAMA, 1963